New research from the Monash Addiction Research Centre and Burnet Institute demonstrates that making the opioid overdose antidote naloxone easily accessible and available free-of-charge to people who are prescribed opioids in Australia would be

A recent study led by Turning Point at Monash University and The University of Sydney, has found that a new treatment for opioid dependence, long-acting injectable buprenorphine,  may have a range of benefits for patients and be

A recent study by Monash University researchers has found that prescription drug monitoring programs (PDMP) can impact healthcare providers’ clinical decisions, resulting in both positive and negatives outcomes for patients.

An interdisciplinary team of researchers from Monash University, Turning Point, the University of Sydney, the University of New South Wales and the Florey Institute have been awarded a $5 million NHMRC Synergy Grant over five years to investigate

Veterans’ health and wellbeing remains an important national health issue in Australia. In April this year, the Federal Government announced a Royal Commission into Defence and Veteran Suicide.

Launched in Melbourne in 2001, International Overdose Awareness Day – which was marked on 31 August – is the world’s largest annual campaign to end overdose.

New research examining ambulance attendances for alcohol-related harms during COVID-19 restrictions in Victoria has found that attendances to homes increased by 9 percent in 2020, with those from more socioeconomic advantaged areas showing the

We all know that an afternoon coffee can make it harder for us to get to sleep, while consuming alcohol may help us fall asleep a little quicker.